Home Newsletters Hepatic Cell News Melatonin Is a Potential Oncostatic Agent to Inhibit HepG2 Cell Proliferation through...

Melatonin Is a Potential Oncostatic Agent to Inhibit HepG2 Cell Proliferation through Multiple Pathways

0
Researchers investigated melatonin’s antitumor molecular mechanisms to inhibit the proliferation of HepG2 cells.
[Heliyon]
7992332 {7992332:BBBBBBBB} apa 50 1 171161 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
Full Article
Exit mobile version